bioRxiv Science⌕ Search

Biology subjects

Frey, B. J.

Publications and source records attributed to Frey, B. J..

11 recordsLinked to original sources

Enigma: An Efficient Model for Deciphering Regulatory Genomics

Genomic sequence-to-function models have emerged as powerful tools for deciphering cis-regulatory grammar to advance our understanding of disease biology and guide therapeutic development. Recent advances have been driven by multi-task training of large transformer-based models on thousands of genome tracks. However, these performance gains have come at significant computational cost for both training and inference, hindering large-scale applications and slowing future model development. Here, rather than continuing to scale model size and add more training tracks, we focus on architectural efficiency and train on a substantially smaller, curated set of genome tracks. Our model Enigma achieves competitive performance with current state-of-the-art models at single-base resolution while substantially reducing computational cost. On zero-shot variant effect prediction benchmarks, Enigma outperforms the leading open-source model, the Borzoi ensemble, while using 10.9% of its compute and improving resolution from 32 bases to a single base. Compared to AlphaGenome, Enigma achieves 90.4 - 97.3% of its performance using 7.5% of its estimated compute. These improvements in efficiency can facilitate further development of models for regulatory genomics. We demonstrate this by fine-tuning Enigma on predicting three new molecular phenotypes -- ChIP-seq, RNA half-life, and translation efficiency -- achieving or exceeding the performance of state-of-the-art task-specific models. We are providing Enigma for non-commercial use to benefit the broader research field. [Formula]Code: https://github.com/deepgenomics/enigma

genomics↗

FlashRNA: An Efficient Model for Regulatory Genomics

Transformer-based genomic sequence-to-function models effectively capture long-range genomic interactions but incur high computational costs due to the quadratic complexity of their self-attention layers. In this work, we introduce FlashRNA, which significantly improves computational and memory efficiency through FlashAttention, advancements in model architecture, and optimized training setup. FlashRNA achieves comparable or slightly improved predictive performance compared to similar sized Borzoi or Flashzoi models, notably without depending on pre-trained weights - a major limitation of Flashzoi. Remarkably, we trained FlashRNA from scratch in one day on a single GPU, significantly accelerating training and inference speed. These improvements can facilitate further developments in models for regulatory genomics by reducing computational cost. We demonstrate this in two downstream applications: 1) we train a large ensemble of 16 FlashRNA models and distill them into a single model to improve performance while maintaining efficiency, and 2) we fine-tune FlashRNA on three prediction tasks - ChIP-seq, RNA half-life, and translation efficiency - achieving performance matching or exceeding state-of-the-art task-specific models. Code: https://github.com/deepgenomics/flashrna

genomics↗

Sequence based prediction of cell type specific microRNA binding and mRNA degradation for therapeutic discovery

MicroRNAs and RNA binding proteins are crucial elements of post-transcriptional gene regulation, which governs the fate of mRNA molecules in the cell. However, the landscape of these regulatory interactions, particularly across different mammalian cell types, remains underexplored. We describe REPRESS, a deep learning model that predicts cell-type-specific microRNA binding and mRNA degradation directly from RNA sequence. REPRESS was trained on AGO2-CLIP, miR-eCLIP and Degradome-Seq data profiling millions of microRNA binding and mRNA degradation sites across multiple cell types in human and mouse. It reveals biology that other state-of-the-art methods did not, such as identifying repressive non-canonical miRNA target sites and decoding the regulatory effects of sequence context and miRNA binding site multiplicity. REPRESS outperforms other advanced methods and neural architectures on a comprehensive suite of seven orthogonal tasks, including identifying genetic variants that affect microRNA binding, predicting out-of-distribution data from massively parallel reporter assays, and predicting canonical and non-canonical miRNA mediated repression. To demonstrate the general utility of REPRESS, we show that it provides insights into novel biology and the design of RNA therapeutics. Code is available at : https://github.com/deepgenomics/repress

genomics↗

Orthrus: Towards Evolutionary and Functional RNA Foundation Models

In the face of rapidly accumulating genomic data, our ability to accurately predict key mature RNA properties that underlie transcript function and regulation remains limited. Pre-trained genomic foundation models offer an avenue to adapt learned RNA representations to biological prediction tasks. However, existing genomic foundation models are trained using strategies borrowed from textual domains that do not leverage biological domain knowledge. Here, we introduce Orthrus, a Mamba-based mature RNA foundation model pre-trained using a novel self-supervised contrastive learning objective with biological augmentations. Orthrus is trained by maximizing embedding similarity between curated pairs of RNA transcripts, where pairs are formed from splice isoforms of 10 model organisms and transcripts from orthologous genes in 400+ mammalian species from the Zoonomia Project. This training objective results in a latent representation that clusters RNA sequences with functional and evolutionary similarities. We find that the generalized mature RNA isoform representations learned by Orthrus significantly outperform genomic foundation models on mRNA property prediction tasks, and requires only a fraction of fine-tuning data to do so. Finally, we show that Orthrus is capable of capturing divergent biological function of individual transcript isoforms.

genomics↗

An RNA foundation model enables discovery of disease mechanisms and candidate therapeutics

Accurately modeling and predicting RNA biology has been a long-standing challenge, bearing significant clinical ramifications for variant interpretation and the formulation of tailored therapeutics. We describe a foundation model for RNA biology, "BigRNA", which was trained on thousands of genome-matched datasets to predict tissue-specific RNA expression, splicing, microRNA sites, and RNA binding protein specificity from DNA sequence. Unlike approaches that are restricted to missense variants, BigRNA can identify pathogenic non-coding variant effects across diverse mechanisms, including polyadenylation, exon skipping and intron retention. BigRNA accurately predicted the effects of steric blocking oligonucleotides (SBOs) on increasing the expression of 4 out of 4 genes, and on splicing for 18 out of 18 exons across 14 genes, including those involved in Wilson disease and spinal muscular atrophy. We anticipate that BigRNA and foundation models like it will have widespread applications in the field of personalized RNA therapeutics.

bioinformatics↗

A graph neural network approach to molecule carcinogenicity prediction

Molecular carcinogenicity is a preventable cause of cancer, however, most experimental testing of molecular compounds is an expensive and time consuming process, making high throughput experimental approaches infeasible. In recent years, there has been substantial progress in machine learning techniques for molecular property prediction. In this work, we propose a model for carcinogenicity prediction, CONCERTO, which uses a graph transformer in conjunction with a molecular fingerprint representation, trained on multi-round muta-genicity and carcinogenicity objectives. To train and validate CONCERTO, we augment the training dataset with more informative labels and utilize a larger external validation dataset. Extensive experiments demonstrate that our model yields results superior to alternate approaches for molecular carcinogenicity prediction.

bioinformatics↗

HiCSR: a Hi-C super-resolution framework for producing highly realistic contact maps

MotivationHi-C data has enabled the genome-wide study of chromatin folding and architecture, and has led to important discoveries in the structure and function of chromatin conformation. Here, high resolution data plays a particularly important role as many chromatin substructures such as Topologically Associating Domains (TADs) and chromatin loops cannot be adequately studied with low resolution contact maps. However, the high sequencing costs associated with the generation of high resolution Hi-C data has become an experimental barrier. Data driven machine learning models, which allow low resolution Hi-C data to be computationally enhanced, offer a promising avenue to address this challenge. ResultsBy carefully examining the properties of Hi-C maps and integrating various recent advances in deep learning, we developed a Hi-C Super-Resolution (HiCSR) framework capable of accurately recovering the fine details, textures, and substructures found in high resolution contact maps. This was achieved using a novel loss function tailored to the Hi-C enhancement problem which optimizes for an adversarial loss from a Generative Adversarial Network (GAN), a feature reconstruction loss derived from the latent representation of a denoising autoencoder, and a pixel-wise loss. Not only can the resulting framework generate enhanced Hi-C maps more visually similar to the original high resolution maps, it also excels on a suite of reproducibility metrics produced by members of the ENCODE Consortium compared to existing approaches, including HiCPlus, HiCNN, hicGAN and DeepHiC. Finally, we demonstrate that HiCSR is capable of enhancing Hi-C data across sequencing depth, cell types, and species, recovering biologically significant contact domain boundaries. AvailabilityWe make our implementation available for download at: https://github.com/PSI-Lab/HiCSR Contactljlee@psi.toronto.edu Supplementary informationAvailable Online

genomics↗

ATP7B Variant c.1934T>G p.Met645Arg Causes Wilson Disease by Promoting Exon 6 Skipping

Wilson Disease is a recessive genetic disorder caused by pathogenic loss-of-function variants in the ATP7B gene. It is characterized by disrupted copper homeostasis resulting in liver disease and/or neurological abnormalities. The variant NM_000053.3:c.1934T>G (Met645Arg) has been reported as compound heterozygous and is highly prevalent among Wilson Disease patients of Spanish descent. Accordingly, it is classified as pathogenic by leading molecular diagnostic centers. However, functional studies suggest that the amino acid change does not alter protein function, leading one ClinVar submitter to question its pathogenicity. Here we used a minigene system and gene-edited HepG2 cells to demonstrate that c.1934T>G causes approximately 70% skipping of exon 6. Exon 6 skipping results in frameshift and stop gain, which is expected to cause loss of ATP7B function. The elucidation of the mechanistic effect for this variant resolves any doubt about its pathogenicity and enables the development of genetic medicines for restoring correct splicing.

genetics↗

Allele-specific transcription factor binding as a benchmark for assessing variant impact predictors

Genetic variation has long been known to alter transcription factor binding sites, resulting in sometimes major phenotypic consequences. While the performance for current binding site predictors is well characterised, little is known on how these models perform at predicting impact of variants. We collected and curated over 132,000 potential allele-specific binding (ASB) ChIP-seq variants across 101 transcription factors (TFs). We then assessed the accuracy of TF binding models from five different methods on these high-confidence measurements, finding that deep learning methods were best performing yet still have room for improvement. Importantly, machine learning methods were consistently better than the venerable position weight matrix (PWM). Finally, predictions for certain TFs were consistently poor, and our investigation supports efforts to use features beyond sequence, such as methylation, DNA shape, and post-translational modifications. We submit that ASB data is a valuable benchmark for variant impact on TF binding.

bioinformatics↗

COSSMO: Predicting Competitive Alternative Splice Site Selection using Deep Learning

MotivationAlternative splice site selection is inherently competitive and the probability of a given splice site to be used also depends strongly on the strength of neighboring sites. Here we present a new model named Competitive Splice Site Model (COSSMO), which explicitly models these competitive effects and predict the PSI distribution over any number of putative splice sites. We model an alternative splicing event as the choice of a 3 acceptor site conditional on a fixed upstream 5 donor site, or the choice of a 5 donor site conditional on a fixed 3 acceptor site. We build four different architectures that use convolutional layers, communication layers, LSTMS, and residual networks, respectively, to learn relevant motifs from sequence alone. We also construct a new dataset from genome annotations and RNA-Seq read data that we use to train our model.\n\nResultsCOSSMO is able to predict the most frequently used splice site with an accuracy of 70% on unseen test data, and achieve an R2 of 60% in modeling the PSI distribution. We visualize the motifs that COSSMO learns from sequence and show that COSSMO recognizes the consensus splice site sequences as well as many known splicing factors with high specificity.\n\nAvailabilityOur dataset is available from http://cossmo.deepgenomics.com.\n\nContactfrey@deepgenomics.com\n\nSupplementary informationSupplementary data are available at Bioinformatics online.

bioinformatics↗

Inference Of The Human Polyadenylation Code

Processing of transcripts at the 3-end involves cleavage at a polyadenylation site followed by the addition of a poly(A)-tail. By selecting which polyadenylation site is cleaved, alternative polyadenylation enables genes to produce transcript isoforms with different 3-ends. To facilitate the identification and treatment of disease-causing mutations that affect polyadenylation and to understand the underlying regulatory processes, a computational model that can accurately predict polyadenylation patterns based on genomic features is desirable. Previous works have focused on identifying candidate polyadenylation sites and classifying sites which may be tissue-specific. What is lacking is a predictive model of the underlying mechanism of site selection, competition, and processing efficiency in a tissue-specific manner. We develop a deep learning model that trains on 3-end sequencing data and predicts tissue-specific site selection among competing polyadenylation sites in the 3 untranslated region of the human genome.\n\nTwo neural network architectures are evaluated: one built on hand-engineered features, and another that directly learns from the genomic sequence. The hand-engineered features include polyadenylation signals, cis-regulatory elements, n-mer counts, nucleosome occupancy, and RNA-binding protein motifs. The direct-from-sequence model is inferred without prior knowledge on polyadenylation, based on a convolutional neural network trained with genomic sequences surrounding each polyadenylation site as input. Both models are trained using the TensorFlow library.\n\nThe proposed polyadenylation code can predict site selection among competing polyadenylation sites in different tissues. Importantly, it does so without relying on evolutionary conservation. The model can distinguish pathogenic from benign variants that appear near annotated polyadenylation sites in ClinVar and inspect the genome to find candidate polyadenylation sites. We also provide an analysis on how different features affect the models performance.

bioinformatics↗